INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Healthy Aging & Longevity desk →

930 studies · page 30 of 39

2020 / Randomized controlled trial

Collagen peptide supplementation for 12 weeks did not reduce knee pain or improve function more than placebo in active middle-aged and older adults.

A randomized controlled trial examined the effects of 10 g/day of collagen peptides (CP) versus placebo for 12 weeks in 167 physically active individuals with self-reported knee pain. Both groups experienced similar reductions in VAS pain scores (-1.6 ± 2.4 with CP vs. -1.9 ± 2.6 with placebo, p = 0.42). KOOS and Lysholm function scores increased significantly in both groups (p < 0.001), but the increases did not differ between groups (p = 0.28 and p = 0.76, respectively). CP also showed no effect on inflammatory, cartilage, or bone biomarkers (p > 0.05).

Bongers CCWG, Ten Haaf DSM, Catoire M, et al. Appl Physiol Nutr Metab, 2020. PMID 31990581

2020 / In vitro study and pilot controlled clinical study

In a pilot study of postmenopausal women, consuming lycopene-rich tomato sauce prevented significant bone density loss compared to controls.

Researchers evaluated the in vitro effects of lycopene on Saos-2 osteoblast cells and conducted a pilot controlled trial assessing bone loss prevention via lycopene-rich tomato sauce in 39 postmenopausal women. In vitro, lycopene modulated Wnt/β-catenin, ERK 1/2, RUNX2, COL1A, and RANKL pathways. In the clinical trial, significant bone density loss was not detected in women consuming tomato sauce, whereas controls experienced bone loss (p = 0.002). Tomato sauce intake also led to a greater reduction in bone alkaline phosphatase compared with controls (18% vs 8.5%, p = 0.03).

Russo C, Ferro Y, Maurotti S, et al. J Transl Med, 2020. PMID 31996227

2020 / Phase II double-blind randomized placebo-controlled trial

A daily cocoa beverage improved 6-minute walk distance at 2.5 hours post-consumption in older adults with peripheral artery disease.

In a 6-month trial, 44 participants with peripheral artery disease were randomized to consume a daily cocoa beverage (15 g cocoa, 75 mg epicatechin) or a placebo. Adjusting for smoking, race, and BMI, cocoa improved 6-minute walk distance by 42.6 m (90% CI, +22.2 to +∞; P=0.005) at 2.5 hours after a final beverage, and by 18.0 m (90% CI, -1.7 to +∞; P=0.12) at 24 hours post-beverage compared to placebo. Calf muscle biopsies showed cocoa improved mitochondrial cytochrome c oxidase activity (P=0.013), increased capillary density (P=0.014), improved perfusion (P=0.098), and reduced central nuclei (P=0.033).

McDermott MM, Criqui MH, Domanchuk K, et al. Circ Res, 2020. PMID 32078436

2020 / Randomized controlled trial

Resveratrol supplementation improved cognitive performance and attenuated the decline in cerebrovascular responsiveness in postmenopausal women.

Postmenopausal women aged 45-85 years (n = 129) were randomized to receive placebo or 75 mg trans-resveratrol twice daily for 12 months. Compared to placebo, resveratrol improved overall cognitive performance (P < 0.001) and attenuated the decline in cerebrovascular responsiveness (CVR) to cognitive stimuli (P = 0.038). The attenuation of CVR decline was associated with a reduction of fasting blood glucose (r = -0.339, P = 0.023).

Thaung Zaw JJ, Howe PRC, Wong RHX Nutrients, 2020. PMID 32244933

2020 / Uncontrolled pre-post trial with young active reference group

Ten weeks of resistance training increased muscle NAD+, NADH, NAMPT protein, and global sirtuin activity in middle-aged, untrained adults.

Sixteen middle-aged, untrained participants completed 10 weeks of full-body resistance training twice weekly, with biopsies taken pre- and post-training, and baseline comparisons made to 15 trained college-aged men. In the middle-aged participants, resistance training increased muscle NAD+ (+127%, p<0.001), NADH (+99%, p=0.002), global SIRT activity (+13%, p=0.036), NAMPT protein (+15%, p=0.014), and citrate synthase activity (+183%, p<0.001). Pre-training NAD+ and NADH were lower in middle-aged participants than young participants (p<0.05), but were similar post-training (p>0.10). The increase in citrate synthase activity was significantly associated with increases in muscle NAD+ (r2=0.592, p=0.001).

Lamb DA, Moore JH, Mesquita PHC, et al. Aging (Albany NY), 2020. PMID 32369778

2020 / Single-blind randomized controlled trial

Drinking lavender herbal tea for two weeks significantly reduced depression and anxiety scores in elderly participants.

A single-blind randomized trial evaluated 60 elderly subjects assigned to receive 2 g lavender teabags twice daily as a decoction for 2 weeks or to an untreated control group. After the intervention, depression scores were significantly lower in the intervention group compared to the control group (16.33 ± 1.49 vs. 18.33 ± 1.84, P < 0.001). Mean differences between intervention and control groups were -2.00 (95% CI: -2.86, -1.13) for depression, -6.40 (95% CI: -9.43, -3.36) for state anxiety, and -4.13 (95% CI: -7.66, -0.60) for trait anxiety.

Bazrafshan MR, Jokar M, Shokrpour N, et al. Complement Ther Med, 2020. PMID 32444033

2020 / Randomized, double-blind, placebo-controlled crossover trial

Resveratrol supplementation for 12 months improved bone mineral density and reduced a bone resorption marker in postmenopausal women.

In the RESHAW trial, postmenopausal women were randomized to receive resveratrol (75 mg twice daily) or placebo in a 24-month crossover design. After 12 months of resveratrol compared to placebo, bone mineral density increased in the lumbar spine (+0.016 ± 0.003 g/cm2) and neck of femur (+0.005 ± 0.002 g/cm2), accompanied by a 7.24% reduction in C-terminal telopeptide type-1 collagen levels. The femoral neck bone mineral density increase improved T-scores (+0.070 ± 0.018) and lowered 10-year fracture risk, with larger effects observed in women with poorer bone biomarker status or those taking vitamin D plus calcium.

Wong RH, Thaung Zaw JJ, Xian CJ, et al. J Bone Miner Res, 2020. PMID 32564438

2020 / Pilot double-blind randomized placebo-controlled trial

Erinacine A-enriched Hericium erinaceus mycelia capsules for 49 weeks improved cognitive scores and contrast sensitivity in patients with mild Alzheimer's disease.

Patients with mild Alzheimer's disease were randomized to receive three 350 mg erinacine A-enriched Hericium erinaceus mycelia (EAHE) capsules per day (5 mg/g erinacine A) or placebo for 49 weeks following a 3-week screening period. After 49 weeks, the EAHE group showed significant improvement in MMSE score, a significant difference in IADL score compared to placebo, and a significant decrease in CASI score was noted only in the placebo group. The EAHE group also achieved significantly better contrast sensitivity and showed differences in biomarkers and neuroimaging ADC values compared to placebo. Four subjects dropped out due to abdominal discomfort, nausea, and skin rash, with no other adverse events reported.

Li IC, Chang HH, Lin CH, et al. Front Aging Neurosci, 2020. PMID 32581767

2020 / Randomized controlled trial (2 x 2 factorial)

Long-term vitamin D3 supplementation did not reduce the risk of depression or improve mood scores in adults aged 50 or older.

In the VITAL-DEP randomized clinical trial, 18,353 participants aged 50 years or older were assigned to vitamin D3 (2000 IU/d) or placebo for a median duration of 5.3 years. Risk of depression or clinically relevant depressive symptoms did not significantly differ between the vitamin D3 group (12.9/1000 person-years) and placebo (13.3/1000 person-years; HR 0.97, 95% CI 0.87 to 1.09; P = .62). There were also no significant differences in depression incidence, recurrence, or change in PHQ-8 mood scores over time (mean difference 0.01 points, 95% CI -0.04 to 0.05 points).

Okereke OI, Reynolds CF, Mischoulon D, et al. JAMA, 2020. PMID 32749491

2020 / Randomized, double-blind, placebo-controlled crossover trial

Resveratrol supplementation improved pain perception, somatic menopausal symptoms, and general well-being in healthy postmenopausal women.

In a 24-month randomized, double-blind, placebo-controlled crossover trial, 125 healthy postmenopausal women received resveratrol (75 mg twice daily) or placebo to assess effects on well-being and cerebrovascular function. Resveratrol supplementation significantly reduced composite pain score (P < 0.001), especially in overweight participants, and this reduction was associated with improved cerebrovascular responsiveness to hypercapnia (R = -0.329, P = 0.014). Somatic menopausal symptoms (P = 0.024) and general well-being (P = 0.010) were also improved.

Thaung Zaw JJ, Howe PRC, Wong RHX Menopause, 2020. PMID 32881835

2020 / Multicenter, randomized, double-blind, placebo-controlled trial

Porcine placental extract did not significantly reduce overall menopausal symptoms versus placebo, but showed benefits in overweight or early menopausal subgroups.

One hundred menopausal Korean women were randomly assigned to receive either 400 mg/day of porcine placental extract (PPE) or a placebo for 12 weeks. While the Kupperman Index (KMI) decreased in both groups, the overall difference between groups was not statistically significant. However, KMI decreased significantly more with PPE than placebo in women with BMI 23 kg/m2 or higher (-18.52 ± 9.09 vs -11.40 ± 10.68, P < 0.05) and in early menopausal women (-17.29 ± 9.07 vs -11.29 ± 10.68, P < 0.05). Estradiol levels also increased significantly in the PPE group at 12 weeks (11.13 ± 35.13 pg/m, P < 0.05).

Lee JY, Lee C, Yoon SH, et al. Taiwan J Obstet Gynecol, 2020. PMID 32917317

2020 / Randomised controlled trial

Five years of combined HIIT and MICT did not lower all-cause mortality compared with national physical activity guidelines in older adults.

Older adults (n=1567) were randomized to twice-weekly HIIT (n=400), MICT (n=387), or following national physical activity guidelines (control, n=780) for five years. All-cause mortality did not differ between the control group and the combined MICT and HIIT group. Compared with controls (4.7% observed mortality), absolute risk reduction was 1.7 percentage points after HIIT (HR 0.63, 95% CI 0.33 to 1.20) and absolute increased risk was 1.2 percentage points after MICT (HR 1.24, 95% CI 0.73 to 2.10). Comparing HIIT to MICT, absolute risk reduction was 2.9 percentage points (HR 0.51, 95% CI 0.25 to 1.02). Controls performed more of their physical activity as HIIT than the MICT group did, achieving an exercise dose between MICT and HIIT.

Stensvold D, Viken H, Steinshamn SL, et al. BMJ, 2020. PMID 33028588

2020 / Randomized two-group parallel-arm study

Intake of 85 g of mango reduced deep wrinkle severity in postmenopausal women, whereas 250 g increased several wrinkle measures.

A randomized parallel-arm study evaluated the effects of 16 weeks of either 85 g or 250 g of Ataulfo mango intake on facial wrinkles and erythema in healthy postmenopausal women with Fitzpatrick skin type II or III. In the 85 g group, deep wrinkle severity decreased significantly after 8 weeks (p = 0.007) and 16 weeks (p = 0.03) compared to baseline, while cheek erythema increased (p = 0.04). In contrast, the 250 g group showed significant increases after 16 weeks in average wrinkle severity (p = 0.049), average wrinkle length (p = 0.007), fine wrinkle severity (p = 0.02), and emerging wrinkle severity (p = 0.02).

Fam VW, Holt RR, Keen CL, et al. Nutrients, 2020. PMID 33158079

2020 / Randomized, double-blinded, placebo-controlled clinical trial

Supplementation with vitamin D3 or vitamin D-enriched mushrooms showed no significant effect on cognitive function or mood in healthy older adults.

A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.

Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304

2019 / Randomised, double-blinded, placebo-controlled crossover trial

Oral saffron supplementation modestly improved visual acuity and electroretinogram parameters in adults with mild to moderate age-related macular degeneration.

A randomized, double-blinded, placebo-controlled crossover trial evaluated the effects of 20 mg/day oral saffron versus placebo for 3 months each in 100 adults with mild/moderate age-related macular degeneration. Mean BCVA improved by 0.69 letters (p = 0.001) and mean-pooled mfERG latency decreased by 0.17 ms (p = 0.04) on saffron compared to placebo. In participants also taking AREDS supplements, mean BCVA improved by 0.73 letters (p = 0.006) and mfERG response density improved by 2.8% (p = 0.038). Adverse events did not differ significantly between groups (p > 0.10).

Broadhead GK, Grigg JR, McCluskey P, et al. Graefes Arch Clin Exp Ophthalmol, 2019. PMID 30343354

2019 / Clinical trial protocol

A clinical trial protocol describes evaluating popular antiaging practices and their combinations using DNA methylation age over 2 years in 5,000 participants.

Researchers initiated a clinical trial protocol recruiting 5,000 subjects aged 45-65 to evaluate popular antiaging practices, including diet, drugs, supplements, and exercise. Participants provide blood samples to measure methylation age at the beginning, middle, and end of a 2-year period, with the primary endpoint being the difference in methylation age over 2 years. The exploratory study aims to detect whether certain combinations of strategies synergize to achieve age retardation of 25% or more.

Mitteldorf J Rejuvenation Res, 2019. PMID 30345885

2019 / Double-blind randomized controlled trial

Metformin attenuated exercise-induced gains in insulin sensitivity, VO2 max, and skeletal muscle mitochondrial respiration in older adults.

Older adults underwent 12 weeks of aerobic exercise training (AET) while randomized double-blind to placebo (n = 26) or metformin (n = 27). Independent of treatment, AET decreased fat mass, HbA1c, fasting plasma insulin, 24-hr ambulant mean glucose, and glycemic variability. However, metformin attenuated improvements in whole-body insulin sensitivity and VO2 max, and abrogated increases in skeletal muscle mitochondrial respiration. Mitochondrial protein synthesis rates were not different between treatments.

Konopka AR, Laurin JL, Schoenberg HM, et al. Aging Cell, 2019. PMID 30548390

2019 / Randomized controlled trial

A 3-month therapeutic yoga program significantly reduced stress incontinence frequency compared to a stretching and strengthening control in older women.

Fifty-six ambulatory women aged 50 or older with daily urinary incontinence were randomized to a 3-month Iyengar-based yoga program or a muscle stretching and strengthening control program; both received self-management education. Over 3 months, total incontinence frequency decreased by an average of 76% in the yoga group versus 56% in controls (P = .07). Stress incontinence frequency decreased by 61% in the yoga group compared to 35% in controls (P = .045), while changes in urgency incontinence frequency showed no significant difference between groups. High retention (89%) was observed with no adverse events directly attributable to the interventions.

Huang AJ, Chesney M, Lisha N, et al. Am J Obstet Gynecol, 2019. PMID 30595143

2019 / Randomized, double-blind, placebo-controlled trial

Vitamin B12-fortified toothpaste significantly increased vitamin B12 status and holotranscobalamin in elderly subjects over 3 months.

A randomized, double-blind, placebo-controlled study evaluated whether toothpaste enriched with 100 µg cyanocobalamin/g could improve vitamin B12 status in 103 elderly subjects over 3 months. In the 92 participants who completed the trial, post-intervention serum vitamin B12 concentrations were higher in the B12 group than placebo [368 (123) vs. 295 (123) pmol/L; p=0.005]. Changes from baseline were significantly greater in the B12 group for vitamin B12 [54 (74) vs. 3 (60) pmol/L, p<0.001], holoTC [21 (34) vs. 2 (32) pmol/L, p=0.007], and tHcy [-0.9 (2.3) vs. 0.3 (1.9) µmol/L, p=0.010]. No side effects were observed.

Zant A, Awwad HM, Geisel J, et al. Aging Clin Exp Res, 2019. PMID 30680547

2019 / Randomized, double-blind trial

Daily freeze-dried blueberry powder improved pain, stiffness, daily activity difficulty, and gait parameters in adults with symptomatic knee osteoarthritis.

In a randomized, double-blind trial, adults aged 45 to 79 with symptomatic knee osteoarthritis consumed either 40 g of freeze-dried blueberry powder (n = 33) or placebo powder (n = 30) daily for four months. The blueberry group experienced significant decreases in WOMAC total score, pain, stiffness, and difficulty performing daily activities (p < 0.05), whereas improvements in total score and daily activities were not seen with placebo. In the blueberry group, normal walking pace single support percentage increased for both limbs (p ≤ 0.007) and double support percentage decreased (p ≤ 0.003). No significant changes were observed in plasma concentrations of TNF-α, IL-1β, IL-6, IL-10, IL-13, MMP-3, MMP-13, and MCP-1 in either group, though trends were observed for IL-13 and MCP-1 in the blueberry group.

Du C, Smith A, Avalos M, et al. Nutrients, 2019. PMID 30699971

2019 / Randomized placebo-controlled double-blind trial

Vitamin D supplementation in deficient elderly individuals modulated immune markers after influenza vaccination without improving antibody titers.

Elderly individuals with vitamin D deficiency were randomized to receive either 100,000 IU/15 days of cholecalciferol (n = 19) or placebo (n = 19) for 3 months, followed by influenza vaccination and immune evaluation 28 days later. Serum 25-(OH)D increased in the supplementation group (20.7 ± 5.7 to 44.3 ± 8.6 ng/mL, p < 0.001). Supplementation led to lower plasma levels of TNFα (p = 0.040) and IL-6 (p = 0.046), higher TGFβ (p = 0.0028), and a lower Th1/Th2 ratio prior to vaccination (0.12 ± 0.05 vs. 0.18 ± 0.05, p = 0.039). However, no differences were found between groups for antibody titers, serum cathelicidin levels, or ROS production.

Goncalves-Mendes N, Talvas J, Dualé C, et al. Front Immunol, 2019. PMID 30800121

2019 / Randomized, placebo-controlled, double-blind trial

Soymilk ingestion immediately after exercise enhanced grip strength, walking speed, and endurance in chronic stroke patients.

Twenty-two chronic stroke patients underwent an 8-week rehabilitation exercise intervention (3 sessions/week, 120 min/session) and were randomly assigned to ingest either soymilk (n=11) or a placebo beverage (n=11) immediately post-exercise. Compared with placebo, immediate soymilk ingestion significantly improved hand grip strength (p=0.021), 8-feet walking speed (p=0.019), walking performance per unit lean mass (p=0.024), and 6-minute walk performance (p=0.016). However, changes in lean mass and the total score for the short physical performance battery (SPPB) did not differ between the groups.

Liao YH, Chen CN, Hu CY, et al. NeuroRehabilitation, 2019. PMID 30856124

2019 / Randomized single-blind, controlled crossover trial

A 5-day intervention with cooked, but not raw, Brassica carinata leaves increased telomerase activity in CD8+ lymphocytes by 25% in healthy volunteers.

In a randomized single-blind, controlled crossover study of 22 healthy volunteers, researchers evaluated the effects of a 5-day intervention with raw or cooked leaves of Brassica carinata on telomerase activity in CD4+ and CD8+ T cells. Both preparations produced a marginal increase in telomerase activity in CD4+ cells compared to baseline. In CD8+ cells, intervention with the cooked material led to a significant 25% increase in telomerase activity (p < 0.05). Whether this intervention has long-term effects on telomere extension in specific T cell subsets remains to be determined.

Tran HTT, Schreiner M, Schlotz N, et al. Nutrients, 2019. PMID 30959753

2019 / Randomized crossover clinical trial

A pistachio-supplemented diet reduced DNA oxidative damage and upregulated telomere-related genes in prediabetic individuals.

In a randomized crossover trial, 49 prediabetic subjects consumed an isocaloric control diet or a pistachio-supplemented diet (including 57 g pistachios/d) for 4 months each, separated by a 2-week washout. Compared with the control diet, the pistachio diet reduced oxidative damage to DNA (mean: -3.5%; 95% CI: -8.07%, 1.05%; P = 0.009). It also significantly upregulated expression of TERT (164%, P = 0.043) and WRAP53 (53%, P = 0.001). Changes in TERT expression were negatively correlated with changes in fasting plasma glucose and HOMA-IR.

Canudas S, Hernández-Alonso P, Galié S, et al. Am J Clin Nutr, 2019. PMID 31051499